Myocardial Ischemia and Arrhythmia

Inhaltsverzeichnis

• Metabolic aspects and channel kinetics in cellular hypoxia.
• Calcium homeostasis, myocardial ischemia and arrhythmogenic impact.
• Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis.
• Arrhythmogenic effects of selective inhibition of cyclic nucleotide phosphodiesterase isoenzymes in pig myocardium.
• Ischemia and early extracellular K+ accumulation in cardiac cells.
• Characteristics of transport processes involved in ischemia and reperfusion.
• Ionic and metabolic progenitors of reperfusion arrhythmias.
• Electrophysiologic properties of cellular hypoxia and myocardial ischemia.
• Anisotropy and anisotropic reentry in myocardial infarction.
• Effects of the sympathetic nervous system on conduction and refractoriness in normal and ischemic myocardium.
• Sympatho-adrenergic activation of the ischemic myocardium and its arrhythmogenic impact.
• Factors determining the arrhythmogenic potency of myocardial ischemia and time-course of ischemia related arrhythmias.
• Pathophysiology of acute ischemia: Potential targets for Antiarrhythmic drugs.
• Acute and chronic myocardial ischemia in the arrhythmogenesis and aggravation of ventricular arrhythmias.
• Risk stratification and prediction of sudden death following myocardial infarction.
• Ventricular tachyarrhythmias, myocardial ischemia and sudden cardiac death in patients with hypertensive heart disease.
• Vascular mechanisms leading to myocardial ischemia and their relation to hypertension, left ventricular hypertrophy and arrhythmias.
• Clinical evidence for the fatal interaction of ventricular tachyarrhythmias, myocardial ischemia and sudden cardiac death.
• Autonomic nervous system, myocardial ischemia, and malignant ventricular arrhythmias: Experimental findings.
• Assessment of autonomic tonus and reflexes in patients after myocardial infarction.
• Clinical aspects in the treatment of ischemia-related ventricular arrhythmias.
• Coronary artery bypass graft surgery for the prevention of sudden cardiac death.
• Myocardial ischemia, ventricular arrhythmias and implantable cardioverter-defibrillators: Importance of stored electrograms.
• Therapeutic consequences of newer studies addressing the problem of myocardial ischemia and ventricular arrhythmias.